NCT03142334 2026-03-10KEYNOTE-564Merck Sharp & Dohme LLCPhase 3 Completed994 enrolled 10 charts 1 FDA
NCT05116189 2026-03-09KEYNOTE-B96Merck Sharp & Dohme LLCPhase 3 Active not recruiting643 enrolled 17 charts 1 FDA
NCT07246863 2026-03-04Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLCCatalYm GmbHPhase 2 Recruiting131 enrolled